Ananda G.C
Introduction:
Rheumatic heart disease is one of the most common heart diseases in developing country. One of the most common complications of Rheumatic Heart Disease is Mitral Stenosis which ultimately lead to pulmonary hypertension and heart failure and death. So, PTMC (Percutaneous Transluminal Mitral Commissurotomy) is a well-established simple, effective, and safe therapeutic intervention for mitral stenosis.
While many literatures reviewed till date have shown that it takes 3-6 months’ time period for the reduction of pulmonary artery pressure after PTMC, this study is designed to see the result in pulmonary artery pressure immediately after procedure.
免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证
分享此文章